Organization Overview
Alternative names
68ga-psma (2020)
ammonia n-13 (2014)
choline c11 (choline c-11) (2017)
fludeoxyglucose f-18 (2014)
sodium fluoride-18f (2014)
acetaminophen (tylenol) (10 trials)
acetylcysteine (mucomyst) (8 trials)
adefovir dipivoxil (hepsera) (2 trials)
albendazole (Albenza) (2 trials)
albuterol (proventil) (6 trials)
alendronic acid (fosamax) (4 trials)
allopurinol (zyloprim) (1 trial)
amiodarone (cordarone) (2 trials)
aripiprazole (abilify) (1 trial)
articaine (Septocaine) (1 trial)
atorvastatin (lipitor) (2 trials)
azithromycin (zithromax) (29 trials)
bacitracin (polysporin) (1 trial)
belatacept (nujolix) (3 trials)
betamethasone (celestone) (4 trials)
bevacizumab (avastin) (17 trials)
bupivacaine (Exparel) (2 trials)
bupropion (wellbutrin) (5 trials)
calcipotriene (dovonex) (2 trials)
calcitriol (rocaltrol) (1 trial)
carboplatin (paraplatin) (15 trials)
casein phosphopeptide amorphous calcium phosphate (1 trial)
chlorhexidine (hibitane) (5 trials)
chlorzoxazone (parafon forte dsc) (1 trial)
cinacalcet (sensipar) (1 trial)
cisplatin (platinol) (12 trials)
citalopram (celexa) (3 trials)
clobetasol (dermovate) (1 trial)
clonidine (catapres) (1 trial)
conjugated equine estrogens (3 trials)
corticotropin (acthar) (1 trial)
cyclosporine (sandimmune) (9 trials)
daclizumab (Zenapax) (3 trials)
deferasirox (exjade) (2 trials)
deferoxamine (desferal) (5 trials)
docetaxel (taxotere) (7 trials)
dolutegravir (tivicay) (2 trials)
doxycycline (vibramycin) (6 trials)
drospirenone (Yasmin) (2 trials)
dupilumab (dupixent) (2 trials)
emtricitabine (emtriva) (10 trials)
entecavir (baraclude) (1 trial)
epinephrine (levophed) (2 trials)
erythromycin (ilosone) (1 trial)
escitalopram (lexapro) (3 trials)
estradiol (progynon depot) (4 trials)
everolimus (zortress) (13 trials)
fesoterodine (toviaz) (1 trial)
florbetapir (Amyvid) (2 trials)
fluorouracil (efudex) (11 trials)
fluoxetine (prozac) (3 trials)
fluticasone (cutivate) (6 trials)
gentamicin (garamycin) (2 trials)
glycopyrronium (robinul) (2 trials)
guselkumab (tremfya) (1 trial)
halobetasol (ultravate) (1 trial)
hepatitis a vaccine, inactivated (vaqta) (1 trial)
hepatitis b vaccine (recombinant) (recombivax) (1 trial)
hydrocodone (hycodan) (2 trials)
ingenol mebutate (picato) (1 trial)
insulin human (humulin) (3 trials)
interferon alpha-2b (Intron-A) (6 trials)
ipratropium (atrovent) (1 trial)
isoniazid (nydrazid) (5 trials)
lamivudine (epivir) (4 trials)
ledipasvir (Harvoni) (2 trials)
levobupivacaine (chirocaine) (4 trials)
lopinavir (Kaletra) (7 trials)
lumefantrine (Coartem) (10 trials)
maraviroc (selzentry) (5 trials)
memantine (namenda) (2 trials)
mesalamine (rowasa) (2 trials)
metformin (glucophage) (3 trials)
methamphetamine (desoxyn) (3 trials)
mifepristone (mifeprex) (3 trials)
mirabegron (myrbetriq) (1 trial)
misoprostol (cytotec) (3 trials)
modafinil (provigil) (6 trials)
moxifloxacin (avelox) (8 trials)
mupirocin (bactroban) (2 trials)
mycophenolate (myfortic) (15 trials)
naltrexone (revia) (32 trials)
neostigmine (bloxiverz) (1 trial)
nevirapine (viramune) (2 trials)
nicotine (nicorette) (11 trials)
nitroglycerin (transderm-nitro) (4 trials)
norepinephrine (levophed) (1 trial)
ocrelizumab (ocrevus) (1 trial)
oxytocin (syntocinon) (15 trials)
paclitaxel (taxol) (16 trials)
parathyroid hormone (Natpara) (2 trials)
pemetrexed (alimta) (2 trials)
phentolamine mesylate (regitine) (1 trial)
phenylephrine (Prefrin) (3 trials)
prednisone (meticorten) (22 trials)
progesterone (progestasert) (2 trials)
pyrimethamine (daraprim) (7 trials)
raltegravir (isentress) (7 trials)
ribavirin (virazole) (4 trials)
risperidone (risperdal) (2 trials)
rivastigmine (exelon) (1 trial)
rocuronium (zemuron) (2 trials)
ropivacaine (naropin) (3 trials)
secukinumab (cosentyx) (1 trial)
sertraline (zoloft) (4 trials)
sevoflurane (ultane) (2 trials)
sildenafil (viagra) (4 trials)
simvastatin (zocor) (5 trials)
sirolimus (rapamune) (8 trials)
sitagliptin (januvia) (12 trials)
sodium dichloroacetate (1 trial)
sofosbuvir (sovaldi) (6 trials)
suvorexant (belsomra) (2 trials)
tacrolimus (prograf) (14 trials)
tenofovir (viread) (12 trials)
tetracycline (tetrex) (1 trial)
tolterodine (detrol) (1 trial)
topiramate (topamax) (4 trials)
tranexamic acid (cyklokapron) (1 trial)
treprostinil (remodulin) (1 trial)
triamcinolone (kenalog) (3 trials)
tropicamide (mydriacyl) (1 trial)
ustekinumab (stelara) (1 trial)
valbenazine (ingrezza) (6 trials)
valganciclovir (valcyte) (5 trials)
varenicline (chantix) (3 trials)
velpatasvir (Epclusa) (3 trials)
venlafaxine (effexor) (1 trial)
voxilaprevir (Vosevi) (1 trial)
abiraterone (zytiga) (4 trials)
acetylsalicylic acid (aspirin) (2 trials)
aldesleukin (proleukin) (4 trials)
alirocumab (praluent) (1 trial)
allogeneic pancreatic islet cells (5 trials)
amlodipine (norvasc) (1 trial)
amodiaquine (camoquin) (3 trials)
Anti-thymocyte Globulin (Rabbit) (Thymoglobulin) (12 trials)
apalutamide (erleada) (3 trials)
atrasentan hydrochloride (2 trials)
autologous bone marrow (2 trials)
autologous mononuclear stem cell (1 trial)
basiliximab (simulect) (2 trials)
beclomethasone (vanceril) (2 trials)
bedaquiline (sirturo) (4 trials)
bicalutamide (casodex) (2 trials)
bleomycin (blenoxane) (1 trial)
bortezomib (velcade) (6 trials)
chlorthalidone (Hygroton) (2 trials)
ciclesonide (alvesco) (1 trial)
cidofovir (vistide) (2 trials)
clarithromycin (biaxin) (1 trial)
clofazimine (lamprene) (4 trials)
clopidogrel (plavix) (3 trials)
colchicine (colbenemid) (1 trial)
cyclophosphamide (cytoxan) (31 trials)
deferiprone (ferriprox) (4 trials)
degarelix acetate (firmagon) (1 trial)
diatrazoate meglumine (Renografin) (1 trial)
Di-deuterated linoleic acid ethyl ester (1 trial)
doxorubicin (Doxil) (11 trials)
efavirenz (sustiva) (5 trials)
eltrombopag (promacta) (2 trials)
estramustine (emcyt) (1 trial)
etanercept (enbrel) (6 trials)
ethambutol (myambutol) (3 trials)
etoposide (vepesid) (19 trials)
fenfluramine (Pondimin) (1 trial)
flutamide (eulexin) (2 trials)
fondaparinux sodium (arixtra) (1 trial)
foscarnet (foscavir) (2 trials)
gabapentin (neurontin) (2 trials)
ganciclovir (cytovene) (5 trials)
hydroxychloroquine (plaquenil) (1 trial)
ibandronate (boniva) (1 trial)
idursulfase (elaprase) (3 trials)
imiglucerase (cerezyme) (1 trial)
immune globulin (human) (2 trials)
indacaterol (arcapta neohaler) (1 trial)
iohexol (Omnipaque) (2 trials)
irinotecan (Camptosar) (18 trials)
ketoconazole (nizoral) (4 trials)
lenalidomide (revlimid) (4 trials)
levodopa (larodopa) (2 trials)
levofloxacin (levaquin) (1 trial)
medroxyprogesterone (provera) (1 trial)
methylprednisolone (medrol) (4 trials)
metoprolol (lopressor) (2 trials)
mitoxantrone (novantrone) (4 trials)
natamycin (natacyn) (4 trials)
nitric oxide (inomax) (1 trial)
pazopanib (votrient) (4 trials)
peripheral blood hematopoietic cell (14 trials)
pyrazinamide (Aldinamide) (2 trials)
radix salviae miltiorhizae (2 trials)
ranibizumab (lucentis) (6 trials)
recombinant human choriogonadotropin alfa (Ovidrel) (1 trial)
Rho(D) Immune Globulin Intravenous (Human) (WinRho) (1 trial)
rifapentine (priftin) (2 trials)
rituximab (rituxan) (21 trials)
rose bengal disodium (1 trial)
salmeterol (serevent) (2 trials)
sargramostim (leukine) (37 trials)
sipuleucel-t (provenge) (3 trials)
sulfamethoxazole (gantanol) (6 trials)
tamoxifen (nolvadex) (5 trials)
temozolomide (temodar) (20 trials)
tiotropium (spiriva) (1 trial)
triamterene (dyrenium) (1 trial)
Tuberculin, Purified Protein Derivative (Tubersol) (1 trial)
valrubicin (valstar) (1 trial)
vincristine (oncovin) (11 trials)
voriconazole (vfend) (4 trials)
warfarin (coumadin) (4 trials)
18f arabinosyl guanine (1 trial)
7-hydroxystaurosporine (1 trial)
abatacept (orencia) (2 trials)
abemaciclib (verzenio) (1 trial)
alemtuzumab (campath) (3 trials)
allogeneic bone marrow derived mesenchymal stem cell (1 trial)
allogeneic cd20 car-t cell (1 trial)
allogeneic cord blood (1 trial)
allogeneic hematopoietic stem cells (Hemacord) (10 trials)
allogeneic lymphocytes (6 trials)
aminolevulinic acid (levulan) (3 trials)
aminosalicylic acid (Paser) (1 trial)
amphetamine (Adderall) (1 trial)
arnebia indigo jade pearl (1 trial)
atezolizumab (tecentriq) (4 trials)
autologous cd34+ cells (4 trials)
autologous cd4 t-cells (1 trial)
autologous hematopoietic cells transduced with a lentiviral vector with dclre1c (1 trial)
autologous regulatory t cells (3 trials)
autologous umbilical cord blood (4 trials)
avelumab (bavencio) (2 trials)
azacitidine (vidaza) (2 trials)
azathioprine (imuran) (2 trials)
bazedoxifene (Duavee) (1 trial)
belimumab (benlysta) (1 trial)
beta carotene (solatene) (1 trial)
binimetinib (mektovi) (4 trials)
bivalent subtype c gp120 (1 trial)
bromocriptine (parlodel) (2 trials)
budesonide (rhinocort) (3 trials)
busulfan (myleran) (13 trials)
canakinumab (ilaris) (1 trial)
cannabidiol (Epidiolex) (2 trials)
capecitabine (xeloda) (8 trials)
celecoxib (celebrex) (3 trials)
cemiplimab (libtayo) (1 trial)
cephalexin (keflex) (2 trials)
ceritinib (zykadia) (2 trials)
cetylpyridinium chloride (1 trial)
choline c11 (choline c-11) (1 trial)
cintredekin besudotox (2 trials)
clemastine (TAVIST) (3 trials)
COVID-19 convalescent plasma (1 trial)
cytarabine (cytosar-u) (11 trials)
dabrafenib (tafinlar) (1 trial)
dactinomycin (cosmegen) (1 trial)
dapagliflozin (farxiga) (2 trials)
daratumumab (darzalex) (2 trials)
dasatinib (sprycel) (2 trials)
daxibotulinumtoxinA (Daxxify) (1 trial)
defibrotide (defitelio) (1 trial)
diphenhydramine (benadryl) (4 trials)
disulfiram (antabuse) (4 trials)
donor-alloantigen-reactive regulatory t cells (1 trial)
drotrecogin alfa, activated (xigris) (1 trial)
durvalumab (imfinzi) (4 trials)
efalizumab (raptiva) (1 trial)
encorafenib (braftovi) (1 trial)
entrectinib (Rozlytrek) (1 trial)
enzalutamide (xtandi) (5 trials)
epirubicin (ellence) (2 trials)
erlotinib (tarceva) (12 trials)
erwinia asparaginase (Erwinaze) (1 trial)
filgrastim (neupogen) (2 trials)
fluconazole (diflucan) (2 trials)
flucytosine (ancobon) (1 trial)
fludarabine (fludara) (16 trials)
fluvastatin (lescol) (1 trial)
gadopenteate dimeglumine (magnevist) (2 trials)
galcanezumab-gnlm (emgality) (1 trial)
gemcitabine (gemzar) (13 trials)
gonadorelin (factrel) (1 trial)
gusperimus trihydrochloride (1 trial)
hepatitis b immune globulin (human) (BayHep B) (1 trial)
herba scutellaria barbata (1 trial)
human papillomavirus 9-valent vaccine, recombinant (Gardasil 9) (1 trial)
human papillomavirus quadrivalent (types 6, 11, 16 and 18) vaccine, recombinant (Gardasil) (4 trials)
ibrutinib (imbruvica) (2 trials)
icosapent ethyl (vascepa) (7 trials)
indomethacin (indocin) (2 trials)
infliximab (remicade) (2 trials)
interferon beta-1b (betaseron) (1 trial)
iobenguane sulfate i-131 (5 trials)
ipilimumab (yervoy) (10 trials)
Isatuximab (Sarclisa) (2 trials)
itraconazole (sporanox) (1 trial)
lactobacillus crispatus (1 trial)
letermovir (prevymis) (1 trial)
leuprolide (lupron) (2 trials)
levetiracetam (keppra) (4 trials)
loperamide (imodium) (1 trial)
lutetium (177Lu) vipivotide tetraxetan (Pluvicto) (2 trials)
lvgp120duocar-t cells (1 trial)
mage-a1-specific t cell receptor-transduced autologous t-cells (1 trial)
masoprocol (actinex) (2 trials)
melphalan (alkeran) (5 trials)
mercaptopurine (purinethol) (2 trials)
methylene blue (proveblue) (1 trial)
mirtazapine (remeron) (1 trial)
mitomycin (mutamycin) (3 trials)
montelukast (singulair) (2 trials)
nitazoxanide (alinia) (1 trial)
octreotide (sandostatin) (1 trial)
ofatumumab (arzerra) (1 trial)
olaparib (lynparza) (2 trials)
omega-3 fatty acids (omacor) (1 trial)
ondansetron (zofran) (2 trials)
osimertinib (tagrisso) (2 trials)
palbociclib (ibrance) (3 trials)
panobinostat (farydak) (4 trials)
pegaspargase (oncaspar) (2 trials)
pegvisomant (somavert) (1 trial)
pembrolizumab (keytruda) (28 trials)
pertuzumab (perjeta) (2 trials)
pexidartinib (Turallo) (3 trials)
pirfenidone (esbriet) (4 trials)
platelet rich plasma (1 trial)
plerixafor (mozobil) (1 trial)
potassium chloride (klor-con) (1 trial)
prednisolone (hydeltra) (1 trial)
prostatic acid phosphatase-sargramostim fusion protein (1 trial)
regadenoson (lexiscan) (1 trial)
regorafenib (stivarga) (1 trial)
ribociclib (kisqali) (1 trial)
rifabutin (mycobutin) (2 trials)
rifaximin (xifaxan) (2 trials)
rilimogene gamvacirepvec (1 trial)
ruxolitinib (jakafi) (3 trials)
silver diammine fluoride (1 trial)
sodium ferric gluconate complex (1 trial)
somatropin (protropin) (1 trial)
sorafenib (nexavar) (6 trials)
spironolactone (aldactone) (1 trial)
succinylcholine (anectine) (1 trial)
sugammadex (bridion) (1 trial)
talazoparib (talzenna) (2 trials)
tazarotene (tazorac) (2 trials)
temsirolimus (torisel) (3 trials)
testosterone (delatestryl) (1 trial)
tetrahydrocannabinol (2 trials)
tocilizumab (actemra) (1 trial)
trametinib (mekinist) (4 trials)
trastuzumab (herceptin) (8 trials)
trastuzumab emtansine (kadcyla) (1 trial)
umbilical cord mesenchymal stem cells (1 trial)
valproic acid (depakene) (3 trials)
vemurafenib (zelboraf) (3 trials)
venetoclax (venclexta) (1 trial)
vinblastine (velban) (1 trial)
vinorelbine (navelbine) (1 trial)
vismodegib (erivedge) (3 trials)
vorinostat (zolinza) (4 trials)
131i-metaiodobenzylguanidine (2 trials)
64cu-dota-daratumumab (1 trial)
aluminum hydroxide (Gaviscon) (2 trials)
anastrozole (arimidex) (1 trial)
atazanavir (reyataz) (2 trials)
attenuated measles vaccine (rubeovax) (1 trial)
autologous anti-h3.3k27m tcr-expressing t-cells (1 trial)
autologous total tumor mrna and pp65 full length (fl) lysosomal associated membrane protein (lamp) mrna loaded dotap liposome vaccine administered intravenously (rna loaded lipid particles, rna-lps) (1 trial)
bendamustine (treanda) (1 trial)
beta-hydroxyisovaleric acid (1 trial)
brigatinib (alunbrig) (1 trial)
brimonidine (alphagan) (1 trial)
cabazitaxel (jevtana kit) (1 trial)
capromab pendetide (Prostascint) (1 trial)
carfilzomib (kyprolis) (2 trials)
cefotaxime (claforan) (1 trial)
clevidipine (cleviprex) (1 trial)
cromoglicic acid (Intal) (1 trial)
cryopreserved ex vivo expanded polyclonal cd4+cd127lo/-cd25+ t regulatory cells (1 trial)
darunavir (prezista) (1 trial)
daunorubicin (cerubidine) (2 trials)
deuterated nicotine (2 trials)
dexmedetomidine (precedex) (4 trials)
dexrazoxane (zinecard) (1 trial)
eprosartan (teveten) (1 trial)
euphorbia kansui extract (1 trial)
exemestane (aromasin) (1 trial)
ex vivo expanded human autologous polyclonal regulatory t cells (2 trials)
fexofenadine (allegra) (1 trial)
fludeoxyglucose f-18 (2 trials)
fosamprenavir (lexiva) (1 trial)
fulvestrant (faslodex) (2 trials)
glyburide (micronase) (1 trial)
hemopoietic stem cell (1 trial)
human fecal microbiota (Reybota) (5 trials)
hydromorphone (diladid) (2 trials)
hydroxypropyl-beta-cyclodextrin (1 trial)
in vitro-treated peripheral blood stem cell (1 trial)
laronidase (aldurazyme) (2 trials)
levocarnitine (carnitor) (2 trials)
metronidazole (flagyl) (1 trial)
minocycline (minocin) (4 trials)
mivacurium (mivacron) (1 trial)
nimodipine (nimotop) (1 trial)
pravastatin (pravachol) (1 trial)
propofol (diprivan) (3 trials)
propranolol (inderal) (2 trials)
rabeprazole (pariet) (3 trials)
romidepsin (istodax) (1 trial)
rosuvastatin (crestor) (4 trials)
salsalate (salflex) (2 trials)
sodium lauryl sulfate (1 trial)
talimogene laherparepvec (Imlygic) (2 trials)
telmisartan (micardis) (1 trial)
topotecan (hycamtin) (2 trials)
tumor necrosis factor (1 trial)
typhoid vi polysaccharide vaccine (Typhim Vi) (2 trials)
ursodeoxycholic acid (1 trial)
vancomycin (Vancocin) (1 trial)
agalsidase alfa (Replagal) (1 trial)
ambrisentan (letairis) (1 trial)
bimatoprost (lumigan) (1 trial)
blueberry allergenic extract (1 trial)
cart-egfrviii t cells (1 trial)
certolizumab pegol (cimzia) (1 trial)
clofarabine (clolar) (1 trial)
cobicistat (stribild) (1 trial)
decitabine (dacogen) (1 trial)
dinitrochlorobenzene (1 trial)
dutasteride (avodart) (1 trial)
empagliflozin (jardiance) (1 trial)
enfuvirtide (fuzeon) (1 trial)
ethinyl estradiol (Estinyl) (1 trial)
gallium citrate ga 67 (1 trial)
glatiramer acetate (copaxone) (1 trial)
hepatitis-a virus (inactivated) / hepatitis-b surface antigen (twinrix) (1 trial)